Clinical Trials List
2023-12-15 - 2024-12-06
Phase I
Recruiting1
Terminated3
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/11
Investigators and Locations
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Mu-Hsin Chang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-Chi Lin Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- Ta-Ching Chen Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
232 participants
